The Library
A simplified search strategy for identifying randomised controlled trials for systematic reviews of health care interventions : a comparison with more exhaustive strategies
Tools
Royle, Pamela and Waugh, Norman. (2005) A simplified search strategy for identifying randomised controlled trials for systematic reviews of health care interventions : a comparison with more exhaustive strategies. BMC Medical Research Methodology, Vol.5 (No.1). p. 23. ISSN 1471-2288
|
Text
WRAP_Waugh_filters.pdf - Published Version Download (269Kb) | Preview |
Official URL: http://dx.doi.org/10.1186/1471-2288-5-23
Abstract
Background It is generally believed that exhaustive searches of bibliographic databases are needed for systematic reviews of health care interventions. The CENTRAL database of controlled trials (RCTs) has been built up by exhaustive searching. The CONSORT statement aims to encourage better reporting, and hence indexing, of RCTs. Our aim was to assess whether developments in the CENTRAL database, and the CONSORT statement, mean that a simplified RCT search strategy for identifying RCTs now suffices for systematic reviews of health care interventions. Methods RCTs used in the Cochrane reviews were identified. A brief RCT search strategy (BRSS), consisting of a search of CENTRAL, and then for variants of the word random across all fields (random$.af.) in MEDLINE and EMBASE, was devised and run. Any trials included in the meta-analyses, but missed by the BRSS, were identified. The meta-analyses were then re-run, with and without the missed RCTs, and the differences quantified. The proportion of trials with variants of the word random in the title or abstract was calculated for each year. The number of RCTs retrieved by searching with "random$.af." was compared to the highly sensitive search strategy (HSSS). Results The BRSS had a sensitivity of 94%. It found all journal RCTs in 47 of the 57 reviews. The missing RCTs made some significant differences to a small proportion of the total outcomes in only five reviews, but no important differences in conclusions resulted. In the post-CONSORT years, 1997–2003, the percentage of RCTs with random in the title or abstract was 85%, a mean increase of 17% compared to the seven years pre-CONSORT (95% CI, 8.3% to 25.9%). The search using random$.af. reduced the MEDLINE retrieval by 84%, compared to the HSSS, thereby reducing the workload of checking retrievals. Conclusion A brief RCT search strategy is now sufficient to locate RCTs for systematic reviews in most cases. Exhaustive searching is no longer cost-effective, because in effect it has already been done for CENTRAL.
| Item Type: | Journal Article |
|---|---|
| Subjects: | R Medicine > R Medicine (General) |
| Divisions: | Faculty of Medicine > Warwick Medical School > Health Sciences |
| Library of Congress Subject Headings (LCSH): | Information storage and retrieval systems -- Medicine, Medicine -- Research, Systematic reviews (Medical research) |
| Journal or Publication Title: | BMC Medical Research Methodology |
| Publisher: | Bio Med Central |
| ISSN: | 1471-2288 |
| Date: | 2005 |
| Volume: | Vol.5 |
| Number: | No.1 |
| Page Range: | p. 23 |
| Identification Number: | 10.1186/1471-2288-5-23 |
| Status: | Peer Reviewed |
| Publication Status: | Published |
| Access rights to Published version: | Open Access |
| References: | 1. Dickersin K, Manheimer E, Wieland S, Robinson KA, Lefebvre C, McDonald S. Development of the Cochrane Collaboration's CENTRAL Register of controlled clinical trials. Eval Health Prof 2002, 25(1):38-64. 2. Alderson P, Green S, Higgins JP, editors. Cochrane Reviewers' Handbook 4.2.2 [updated March 2004]. In: The Cochrane Library, Issue 2, 2004; Section 5. Chichester, UK: John Wiley & Sons, Ltd, 2004. 3. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996, 276(8):637-639. 4. Moher D, Schulz KF, Altman D, CONSORT Group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001, 285(15):1987-1991. 5. Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA 2001, 285(15):1992-1995. 6. Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database Syst Rev 2004, 2(2):CD003225. 7. Badger C, Preston N, Seers K, Mortimer P. Benzo-pyrones for reducing and controlling lymphoedema of the limbs. Cochrane Database Syst Rev 2004, 2(2):CD003140. 8. Zhang D. Benzo-pyrones in the treatment of chronic lymphoedema of the arms and legs. Zhonghua Yi Xue Za Zhi 1990, 70(11):655-657. 9. Chang TS, Gan JL, Fu KD, Huang WY. The use of 5,6 benzo-[alpha]-pyrone (coumarin) and heating by microwaves in the treatment of chronic lymphedema of the legs. Lymphology 1996, 29(3):106-111. 10. Stensrud P, Sjaastad O. Comparative trial of Tenormin (atenol) and Inderal (propranolol) in migraine. Headache 1980, 20(4):204-207. 11. Stensrud P, Sjaastad O. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine. Ups J Med Sci Suppl 1980, 31:37-40. 12. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev 2004, 2(2):CD004804. 13. Marshall M, Lockwood A. Early Intervention for psychosis. Cochrane Database Syst Rev 2004, 2(2):CD004718. 14. Wu HM, Tang JL, Sha ZH, Cao L, Li YP. Interventions for preventing infection in nephrotic syndrome. Cochrane Database Syst Rev 2004, 2(2):CD003964. 15. Koning S, Verhagen AP, Suijlekom-Smit LW, Morris A, Butler CC, van der Wouden JC. Interventions for impetigo. Cochrane Database Syst Rev 2004, 2(2):CD003261. 16. Rees K, Bennett P, West R, Davey SG, Ebrahim S. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev 2004, 2(2):CD002902. 17. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev 2004, 2(2):CD003048. 18. Chow TK, To E, Goodchild CS, McNeil JJ. A simple, fast, easy method to identify the evidence base in pain-relief research: validation of a computer search strategy used alone to identify quality randomized controlled trials. Anesth Analg 2004, 98(6):1557-65, table. 19. Egger M, Juni P, Bartlett C, Holenstein F, Sterne J. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess 2003, 7(1):1-76. 20. Badger C, Seers K, Preston N, Mortimer P. Antibiotics / anti-inflammatories for reducing acute inflammatory episodes in lymphoedema of the limbs. Cochrane Database Syst Rev 2004,(2):CD003143. 21. Kasseroller R. Erysipelprophylaxe beim sekundaren lymphoedem mit selen. Der Allgemeinartzt 1996, 3:244-247. 22. Dretzke J, Toff WD, Lip GY, Raftery J, Fry-Smith A, Taylor R. Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block. Cochrane Database Syst Rev 2004, 2(2):CD003710. 23. Davis MJ, Mundin HA, Mews GC, Cope GD. Functional benefits of physiologic compared with ventricular pacing in complete heart block. Clin Prog Electrophysiol Pacing 1985, 3(6):457-460. 24. Linszen D, Dingemans PM, Lenior ME, Scholte WF, Goldstein M. Early family and individual interventions and relapse in recent-onset schizophrenia and related disorders. Ital J Psychiatry Behav Sci 1998, 8(2):77-84. 25. Linszen DH, Dingemans PMAJ, Scholte WF, Lenior ME, Goldstein M. Early recognition, intensive intervention and other protective and risk factors for psychotic relapse in patients with first psychotic episodes in schizophrenia. Int Clin Psychopharmacol 1998, 13(SUPPL. 1):S7-S12. 26. Arata J, Kanzaki H, Kanamoto A, Okawara A, Kato N, Kumakiri M, Shimizu T, Ishibashi Y, Nogita T, Iozumi K, Harada S, Nakanishi H, Hyang YS, Okouchi H, Takano S, Ohara K, Ota T, Shishiba T, Nakabayashi Y. A double blind comparative study of cefdinir and cefaclor in skin and skin structure infections. Chemotherapy 1989, 37(SUPPL. 2):1016-1042. 27. Arata J, Yamamoto Y, Tamaki H, Ookawara A, Fukaya T, Ishibashi Y, Shimozuma M, Iozumi T, Kukita A, Kimura Y, Takahashi H, Sasaki J, Nishiwaki M, Urushibata O, Tomizawa T, Eto H, Kurihara S, Morohashi M, Seki T. Double-blind study of lomefloxacin vs. norfloxacin in the treatment of skin and soft tissue infections. Chemotherapy 1989, 37(4):482-503. 28. Bass JW, Chan DS, Creamer KM, Thompson MW, Malone FJ, Becker TM, Marks SN. Comparison of oral cephalexin, topical mupirocin and topical bacitracin for treatment of impetigo. Pediatr Infect Dis J 1997, 16(7):708-710. 29. Koranyi KI, Burech DL, Haynes RE. Evaluation of bacitracin ointment in the treatment of impetigo. Ohio State Medical Journal 1976, 72(6):368-370. 30. Moraes-Barbosa AD. Comparative study between topical 2% sodium fusidate and oral association of chloranphenicol/neomycin/bacitracin in the treatment of staphylococcic impetigo in new-born. Arq Bras Med 1986, 60(6):509-511. 31. Park SW, Wang HY, Sung HS. A study for the isolation of the causative organism, antimicrobial susceptibility tests and therapeutic aspects in patients with impetigo. Korean J Dermatol 1993, 31:312- 319. 32. Pruksachatkunakorn C, Vaniyapongs T, Pruksakorn S. Impetigo: an assessment of etiology and appropriate therapy in infants and children. J Med Assoc Thai 1993, 76(4):222-229. 33. Sutton JB. Efficacy and acceptability of fusidic acid cream and mupirocin ointment in facial impetigo. Curr Ther Res 1992, 51(5):673-678. 34. Tamayo L, De la Luz OM, Sosa de Martinez MC. Rifamycin and mupirocin in the treatment of impetigo. Dermatol Rev Mex 1991, 35(2):99-103. 35. Gabriel M, Gagnon JP, Bryan CK. Improved patients compliance through use of a daily drug reminder chart. Am J Public Health 1977, 67(10):968-969. 36. Hamilton GA, Roberts SJ, Johnson JM, Tropp JR, Anthony-Odgren D, Johnson BF. Increasing adherence in patients with primary hypertension: an intervention. Health Value 1993, 17:3-11. 37. Kerr JA. Adherence and self-care. Heart Lung 1985, 14(1):24-31. 38. Morisky DE, DeMuth NM, Field-Fass M, Green LW, Levine DM. Evaluation of family health education to build social support for long-terms control of high blood pressure. Health Education Quarterly 1985, 12(1):35-50. 39. Rehder TL, McCoy LK, Blackwell B, Whitehead W, Robinson A. Improving medication compliance by counseling and special prescription container. Am J Hosp Pharm 1980, 37(3):379-385. 40. Dou ZY, Wang JY, Liu YP. Preventive efficiency of low-dose IVIgc on infection in nephrotic synrome. Chin J Biologicals 2000, 13(3):160. 41. Li RH, Peng ZP, Wei YL, Liu CH. Clinical observation on Chinese medicinal herbs combined with predisone for reducing the risks of infection in children with nephrotic syndrome. Inf J Chin Med 2000, 7(10):60-61. 42. Zhang YJ, Wang Y, Yang ZW, Li XT. Clinical investigation of thymosin for preventing infection in children with primary nephrotic syndrome. Chin J Contemp Pediatr 2000, 2(3):197-198. 43. Tong LZ, Mi LZ. Preventive efficiency of IVIgG on secondary nosocomial in nephrotic syndrome. Mod Rehabil 1998, 2(3):236. 44. Sugita T, Togawa M. Efficacy of Lactobacillus preparation biolactis powder in children with rotavirus enteritis. Jpn J Pediatr 1994, 47:2755-2762. 45. Gallacher JE, Hopkinson CA, Bennett P, Burr ML, Elwood PC. Effect of stress management on angina. Psychol Health 1997, 12(4):523-532. 46. Mitsibounas DN, Tsouma-Hadjis ED, Rotas VR, Sideris DA. Effect of group psychosocial intervention on coronary risk factors. Psychother Psychosom 1992, 58:97-102. 47. Siebenhofer A, Plank J, Berghold A, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev 2004, 2(2):CD003287. 48. Iwamoto Y, Akanuma Y, Niimi H, Sasaki N, Tajima N, Kawamori R. Comparison between insulin aspart and soluble human insulin in type 1 diabetes (IDDM) patients treated with basal-bolus insulin therapy - Phase III clinical trial in Japan. J Japan Diab Soc 2001, 44(10):799-811. 49. Duhmke RM, Cornblath DD, Hollingshead JR. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2004, 2(2):CD003726. 50. Leppert W. Analgesic efficacy and side effects of oral tramadol and morphine administered orally in the treatment of cancer pain. Nowotwory 2001, 51(3):257-266. |
| URI: | http://wrap.warwick.ac.uk/id/eprint/52147 |
Actions (login required)
![]() |
View Item |
Tools
Tools

